Coleen Klasmeier

Summary

Publications

  1. doi request reprint Congress should clarify the circumstances under which drug makers can communicate results on comparative effectiveness
    Coleen Klasmeier
    Sidley Austin, Washington, DC, USA
    Health Aff (Millwood) 31:2220-4. 2012

Detail Information

Publications1

  1. doi request reprint Congress should clarify the circumstances under which drug makers can communicate results on comparative effectiveness
    Coleen Klasmeier
    Sidley Austin, Washington, DC, USA
    Health Aff (Millwood) 31:2220-4. 2012
    ..Otherwise, the Food and Drug Administration risks losing First Amendment arguments in cases involving the agency's regulation of the communications-or "speech"-of drug manufacturers...